Hydroxylated-Cpd 5: Possible 'better' arylator on cell growth inhibition

Bulletin of the Korean Chemical Society

Volumn 25, Issue 9, 2004, Pages 1297-1298

  Ham, Seung Wook ^a   Lee, Siyeon ^a  

^a Chung Ang University   (South Korea)

Author keywords

Cdc25 phosphatase; Cell growth inhibition; Naphthoquinone; Reduction potential

Indexed keywords

NAPHTHOQUINONE; PROTEIN TYROSINE PHOSPHATASE; QUINONE DERIVATIVE;

ARTICLE; ARYLATION; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYDROXYLATION; PROTEIN PHOSPHORYLATION; REDUCTION;

EID: 4644257269     PISSN: 02532964     EISSN: None     Source Type: Journal    
DOI: 10.5012/bkcs.2004.25.9.1297     Document Type: Article

References (28)

1. Russell, P.; Nurse, P. Cell 1986, 45, 145.
2. (a) Galaktionov, K.; Beach, D. Cell 1991, 67, 1181.
3. (b) Jinno, S.; Suto, J.; Nagata, A.; Igarashi, M.; Kanaoka, Y.; Nojima, H.; Okayama, H. EMBO J. 1994, 13, 1549.
4. (c) Nagata, A.; Igarashi, M.; Jinno, S.; Suto, K.; Okayama, H. New Biol. 1991, 3, 959.
5. (d) Sadhu, K.; Reed, S. I.; Richardson, H.; Russell, P. Proc. Natl. Acad. Sci. USA 1990, 87, 5139.
6. (a) Forrest, A. R.; McCormack, A. K.; DeSouza, C. P.; Sinnamon, J. M.; Tonks, I. D.; Hayward, N. K.; Ellem, K. A.; Gabrielli, B. G. Biochem. Biophys. Res. Commun. 1999, 260, 510.
7. (b) Wegener, S.; Hampe, W.; Herrmann, D.; Schaller, H. C.; Wegener, S.; Hampe, W.; Herrmann, D.; Schaller, H. C. Eur. J. Cell Biol. 2000, 79, 810.
8. (c) Hernandez, S.; Hernandez, L.; Bea, S.; Pinyol, M.; Nayach, I.; Bellosillo, B.; Nadal, A.; Ferrer, A.; Fernandez, P. L.; Montserrat, E.; Cardesa, A.; Campo, E. Int. J. Cancer 2000, 89, 148.
9. For the review, see: Prevost, G. P.; Brezak, M. C.; Goubin, F.; Mondesert, O.; Galcera, M. O.; Quaranta, M.; Alby, F.; Lavergne, O.; Ducommun, B. Prog. Cell Cycle Res. 2003, 5, 225.
10. For the review, see: (a) Eckstein, J. W. Invest. New Drugs 2000, 18, 149.
11. (b) Pesttell, K. E.; Ducruet, A. P.; Wipf, P.; Lazo, J. S. Oncogene 2002, 19, 6607.
12. (c) Lyon, M. A.; Ducruet, A. P.; Wipf, P.; Lazo, J. S. Nat. Rev. Drug Discov. 2002, 1, 961.
13. (a) Ham, S. W.; Park, H. J.; Lim, D. H. Bioorg. Chem. 1997, 25, 33.
14. (b) Ham, S. W.; Park, J.; Lee, S. J.; Kim, W.; Kang, K.; Choi, K. H. Bioorg. Med. Chem. Lett. 1998, 8, 2507.
15. (c) Nishikawa, Y.; Carr, B. I.; Wang, M.; Kar, S.; Finn, F.; Dowd, P.; Zheng, Z. B.; Kerns, J.; Naganathan, S. J. Biol Chem. 1995, 270, 28304.
16. (d) Lazo, J. S.; Nemoto, K.; Pestell, K. E.; Cooley, K.; Southwick, E. C.; Mitchell, D. A.; Furey, W.; Gussio, R.; Zaharevitz, D. W.; Joo, B.; Wipf, P. Mol. Pharmacol 2002, 61, 720.
17. (e) Lazo, J. S.; Aslan, D. C.; Southwick, E. C.; Cooley, K. A.; Ducruet, A. P.; Joo, B.; Vogt, A.; Wipf, P. J. Med. Chem. 2001, 44, 4042.
18. Tamura, K.; Southwick, E. C.; Kerns, J.; Rosi, K.; Carr, B. I.; Wilcox, C.; Lazo, J. S. Cancer Res. 2000, 60, 1317.
19. Vogt, A.; Adachi, T.; Ducruet, A. P.; Chesebrough, J.; Nemoto, K.; Carr, B. I.; Lazo, J. S. J. Biol. Chem. 2001, 276, 20544.
20. Biochemistry of Quinones; Morton, R. A., Ed.; Academic Press: New York, 1965.
21. Wardman, P. Curr. Med. Chem. 2001, 8, 739.
22. (a) Lind, C.; Hochstein, P.; Ernster, L. Arch. Biochem. Biophys. 1982, 216, 178.
23. (b) Thor, H.; Smith, M. T.; Hartzell, P.; Bellomo, G.; Jewell, S.; Orrenius, S. J. Biol. Chem. 1982, 257, 12419.
24. (c) Morrison, H.; Jernström, B.; Nordenskjold, M.; Thor, H.; Orrenius, S. Biochem. Pharmacol. 1984, 33, 1763.
25. (a) Hochstein, P. Fundam. Appl. Toxicol. 1983, 3, 215.
26. (b) Lind, C.; Cadenas, E.; Hochstein, P.; Ernster, E. Methods Enzymol. 1990, 186, 287.
27. Wardman, P. J. Phys. Chem. Ref. Data 1989, 18, 1637.
28. Ham, S. W.; Choe, J.; Wang, M.-F.; Peyregne, V.; Carr, B. I. Bioorg. Med. Chem. Lett. 2004, 14, 4103.